HIGHLIGHTS
- who: Ana Carolina B. Sant’Anna-Silva and colleagues from the Oroboros Instruments GmbH, Innsbruck, Austria Institute of Human Genetics, Medical University Innsbruck, Innsbruck, Austria have published the research: Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells, in the Journal: Cancers 2021, x of /2021/
- what: In this study, the fate of exogenous succinate in prostate cancer cells was investigated towards energy transformation, mitochondrial physiology, and tumorigenic potential. The focus of this study is a comparison of cells representing an early tumor stage with a high risk of progression, LNCaP cells, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.